Her training incorporated a PhD investigating the value of expression profiling in predicting response of breast cancers to neoadjuvant chemotherapy at the ICR/ RMH and she has retained an interest in genomic profiling and neoadjuvant therapy for breast cancers. She is a local PI on a range of breast studies, sits on the TMG and IDMC of a number of breast radiation and systemic treatment studies and was formally was a member of the BCSG. She contributes to national meetings by lecturing and participating in expert panels.
Suzy Cleator
BackDr Susan Cleator has been a Clinical Oncology Consultant at Imperial specialising in management of breast cancer by systemic and radiation treatments since 2005.
